Olcay Y Jones Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

1/2020	Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate.
6/2006	Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.
4/2006	Anakinra therapy in a child with systemic-onset juvenile rheumatoid arthritis after human herpesvirus 6 encephalitis.
1/2003	Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olcay Y Jones Research Topics

Disease

4	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2020 - 01/2003
3	Dermatomyositis (Dermatopolymyositis) 01/2023 - 06/2011
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2008
3	Infections 06/2006 - 01/2003
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2023 - 06/2021
2	Mevalonate Kinase Deficiency 01/2022 - 01/2022
2	Necrosis 01/2022 - 01/2022
2	Cryopyrin-Associated Periodic Syndromes 01/2022 - 01/2022
2	Myositis (Idiopathic Inflammatory Myopathies) 12/2013 - 11/2013
1	Edema (Dropsy) 01/2023
1	COVID-19 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Rheumatic Diseases (Rheumatism) 06/2021
1	Fever (Fevers) 01/2021
1	Rheumatic Fever (Acute Articular Rheumatism) 01/2020
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2020
1	Muscular Atrophy (Muscle Atrophy) 12/2013
1	Inflammation (Inflammations) 03/2012
1	Calcinosis 03/2012
1	Skin Diseases (Skin Disease) 03/2012
1	Vasculitis (Vasculitides) 01/2008
1	Exanthema (Rash) 05/2006
1	Arthritis (Polyarthritis) 05/2006
1	Rheumatoid Arthritis 04/2006
1	Encephalitis (Encephalitis, Rasmussen) 04/2006
1	Human Herpesvirus 6 encephalitis 04/2006

Drug/Important Bio-Agent (IBA)

4	Interleukin-1 (Interleukin 1)IBA 01/2022 - 04/2006
2	Abatacept (Orencia)FDA Link 01/2023 - 03/2012
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 01/2022
2	AutoantibodiesIBA 12/2013 - 11/2013
2	Etanercept (Enbrel)FDA Link 06/2006 - 01/2003
1	Interleukin-2 (IL2)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	InterferonsIBA 01/2023
1	Janus Kinase InhibitorsIBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Adalimumab (Humira)FDA Link 01/2020
1	EnzymesIBA 12/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2012
1	sodium thiosulfate FDA Link 03/2012
1	Antinuclear AntibodiesIBA 05/2006
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2006

Therapy/Procedure

7	Therapeutics 06/2023 - 04/2006
1	Hematopoietic Stem Cell Transplantation 06/2023
1	Nebulizers and Vaporizers (Inhaler) 01/2022
1	Investigational Therapies (Experimental Therapy) 06/2021
1	Transplantation 06/2021
1	Immunomodulation 06/2021
1	Patient Transfer (Patient Dumping) 06/2011
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2008